https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drug-data-could-boost-companies-case-us-coverage-analysts-2023-08-10/
0
0
8/10/23 at 6:03am
Organization
Reuters
Author
Patrick Wingrove
New data on the heart benefit of an obesity drug from Novo Nordisk <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> increases the chances of a pay-off for it and Eli Lilly, which have spent a record amount on U.S. lo…
Create an account
or login to join the discussion